title: Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsis.
authors.forename: Anne Cornélie J M
authors.initials: AC
authors.lastname: de Pont
authors.forename: Catherine S C
authors.initials: CS
authors.lastname: Bouman
authors.forename: Evert
authors.initials: E
authors.lastname: de Jonge
authors.forename: Margreeth B
authors.initials: MB
authors.lastname: Vroom
authors.forename: Harry R
authors.initials: HR
authors.lastname: Büller
authors.forename: Marcel
authors.initials: M
authors.lastname: Levi
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D006440:Hemofiltration / Q000379:methods*; D006801:Humans; D010314:Partial Thromboplastin Time; D011486:Protein C / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy / Q000628:therapy*; D013927:Thrombosis / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D011486:Protein C; D011994:Recombinant Proteins